Faes Farma, SA Financials

Market Capitalization €1.05 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	11.27
Forward PE	11.66
Price to Sales TTM	€2.09
Price to Book MRQ	€1.54
Enterprise to Revenue	2.06
Enterprise to EBITDA	8.29

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-06-30
Profit Margin	19.36%
Operating Margin	21.76%
Return on Assets TTM	11.84%
Return on Equity TTM	13.85%

Income Statement

Revenue TTM	€504,038,016
Revenue per Share TTM	€1.62
Quarterly Revenue Growth	9.40%
Gross Profit TTM	€334,156,992
EBITDA	€155,362,000
Net Income to Common TTM	€97,585,000
Diluted EPS TTM	€0.30
Quarterly Earnings Growth YoY	1.50%

Balance Sheet

Total Cash MRQ	€69,841,000
Total Cash per Share MRQ	€0.22
Total Debt MRQ	€
Total Debt to Equity MRQ	6.92
Current Ratio MRQ	2.74
Book Value per Share MRQ	€2.20

Cash Flow

Operating Cash Flow TTM	€79,648,000
Levered Free Cash Flow TTM	€91,902,000

FAE Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	311,248,992
Float Shares	288,294,100
Avg 10 Volume	174,125
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	7.30%
% Held by Institutions	19.00%

Stock Price Summary

Beta	0.50
Fifty Two Week Low	€2.91
Fifty Two Week High	€3.83
Fifty Two Week Change	12.32%
Day 50 MA	€3.48
Day 200 MA	€3.55

Dividends and Splits

Forward Annual Dividend Rate	€0.08
Forward Annual Dividend Yield	2.38%
Trailing Annual Dividend Rate	€0.16
Trailing Annual Dividend Yield	4.55%
Payout Ratio	51.66%
Dividend Date
Ex Dividend Date	2025-01-09
Last Split Factor
Last Split Date	2023-04-12